Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
- 6 June 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 390 (10094), 555-566
- https://doi.org/10.1016/s0140-6736(17)31266-7
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's LymphomaJournal of Clinical Oncology, 2012
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II StudyJournal of Clinical Oncology, 2012
- EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma*Blood, 2011
- Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerJournal of Clinical Oncology, 2011
- Quality of life and psychological distress in patients with cutaneous lymphomaBritish Journal of Dermatology, 2009
- Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)Blood, 2006
- EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndromeEuropean Journal of Cancer, 2006
- Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinionBritish Journal of Dermatology, 2006
- Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patientsJournal of the American Academy of Dermatology, 2003
- Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimatesJournal of Clinical Epidemiology, 1995